Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion

BACKGROUND: Conjunctivitis is common in patients with atopic dermatitis (AD) in general and a commonly reported adverse event in AD clinical trials with dupilumab. OBJECTIVE: To survey opinions and experience about conjunctivitis occurring in AD, including those during dupilumab treatment in a group...

Descripción completa

Detalles Bibliográficos
Autores principales: Thyssen, J.P., de Bruin‐Weller, M.S., Paller, A.S., Leshem, Y.A., Vestergaard, C., Deleuran, M., Drucker, A.M., Foelster‐Holst, R., Traidl‐Hoffmann, C., Eyerich, K., Taieb, A., Su, J.C., Bieber, T., Cork, M.J., Eichenfield, L.F., Guttman‐Yassky, E., Wollenberg, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Guidelines and Position Statements
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619239/
https://www.ncbi.nlm.nih.gov/pubmed/31056788
http://dx.doi.org/10.1111/jdv.15608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619239/
https://www.ncbi.nlm.nih.gov/pubmed/31056788
http://dx.doi.org/10.1111/jdv.15608

Ejemplares similares